Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
ARPA-H launches $63M effort to build FDA-authorized AI agents for heart failure care
The Advanced Research Projects Agency for Health (ARPA-H) launched a $62.7 million effort to develop a patient-facing agentic clinical AI system for cardiovascular care, specifically to treat heart | A key aspect of the initiative is close collaboration with the FDA to establish a regulatory framework for a new class of autonomous clinical AI.
TL;DRAI
ARPA-H launches ADVOCATE ($62.7M) for AI agents monitoring heart failure and escalating to clinicians. First FDA regulatory precedent for generative AI in clinical settings, unlocking reimbursement pathways and deployment; $28 billion annual savings potential.
1,522 words~7 min read
